Mucociliary clearance is essential to the defense mechanisms of the respiratory system. Loss of normal Mucociliary clearance contributes to the pathogenesis of genetic and acquired lung diseases. 
Introduction
Mucociliary clearance is an essential aspect of the innate defense mechanisms of the lung. Ciliated cells and mucus secreting cells within the pulmonary epithelium act in concert to remove potentially harmful substances, such as bacteria, toxins, and particulates, from the lungs (Knowles and Boucher, 2002) . Disruption of normal mucociliary clearance in hereditary and acquired respiratory diseases results in mucus plugging of the airways, decreased pulmonary function and an increased risk of secondary infection. In asthma, which affects an estimated 15 million people in the United States alone, a decreased ratio of ciliated cells to mucous cells is observed (Elias et al., 1999; Lundgren et al., 1988) . Respiratory infections with the paramyxovirus respiratory syncytial virus (RSV) result in significant seasonal morbidity and mortality, particularly in individuals with underlying respiratory or cardiac disease. One hallmark of RSV infection is hyperplasia of mucus secreting cells and loss of ciliated cells from the respiratory epithelium (Tristam et al., 1998) . Loss of ciliated cells and mucous cell hyperplasia also occurs in response to environmental toxins such as smoke (Sisson et al., 1994) . Following injury to the airway, regeneration of the normal airway epithelial barrier may occur through proliferation and differentiation of populations of airway epithelial cells. The specific population of cells required has not been clearly identified although potential precursor populations have been proposed (Borthwick et al., 2001; Giangreco et al., 2002; Park et al., 2005) .
Foxj1 is a member of the forkhead box family of transcription factors and is expressed in the ciliated cells of the lung, choroid plexus and reproductive tracts, as well as in the embryonic kidney and the node of the pre-somite stage embryo (Blatt et al., 1999; Hackett et al., 1995; Lim et al., 1997; Pelletier et al., 1998; Tichelaar et al., 1999; Zhang et al., 2004) In the developing mouse and human lung, foxj1 expression is restricted to the proximal pulmonary epithelium and is first expressed during the late pseudoglandular stage of lung development prior to the appearance of ciliated epithelial cells (Hackett et al., 1995; Pelletier et al., 1998) . Targeted mutation of the mouse foxj1 gene results in an absence of 9+2 cilia and defects in left-right asymmetry (Brody et al., 2000; Chen et al., 1998) . The pulmonary epithelium of foxj1 -/-mice demonstrates a complete absence of 9+2 ciliary axonemes. Basal bodies are not localized to the apical cell compartment as in wild type epithelium but are instead distributed throughout the cytoplasm (Brody et al., 2000; Gomperts et al., 2004) . The absence of foxj1 also results in a decrease in the cytoskeletal anchoring proteins ezrin and EBP-50 in the apical cell compartment. Ezrin and EBP-50 thus act by anchoring basal bodies to the apical cytoskeleton (Gomperts et al., 2004; Huang et al., 2003) . Although foxj1 is essential for cilia formation, mutations in the foxj1 gene have, as of yet, not been identified in human diseases with abnormalities of cilia formation (Maiti et al., 2000) . Decreased foxj1 expression, however, has been reported in paromyxovirus infection in mice as well as in human respiratory epithelium following RSV infection (Look et al., 2001 ).
The Th2 cytokines IL-4 and IL-13 play central roles as molecular mediators of the pulmonary epithelial changes seen in asthma, as well as in acquired pulmonary diseases (Yang et al., 2006) . The secretion of Th2 cytokines has pleiotropic effects on the pulmonary epithelium. These effects include inflammation with the recruitment of lymphocytes and eosinophils, mucous cell metaplasia and hyperplasia, loss of ciliated cells and altered ciliary beat frequency, and fibrosis (Laoukili et al., 2001; Zhu et al., 1999) . Increased airway levels of IL-13 have been demonstrated in asthma, as well as in RSV infection (Johnson et al., 2003; Renauld, 2001; Tekkanat et al., 2001 ).
Phosphorylation of STAT-6 in response to IL-13 results in STAT-6 translocation to the nucleus where it can activate or inhibit gene expression (Matsukura et al., 2001; Nguyen and Benveniste, 2000) . Distinct changes in the transcriptional programs of airway cells have been demonstrated in response to IL-13 (Lee et al., 2001) . Understanding the molecular and cellular regulation of these airway epithelial changes in response to cytokines is essential to elucidating the pathogenic mechanisms of asthma and respiratory infections, as well as the development of novel therapeutic approaches to lung disease.
Normal mucociliary clearance requires both the appropriate secretion of mucus and functional cilia in the airways. Given the central role of disturbed mucociliary clearance in lung disease, elucidating the cellular and molecular mechanisms of mucous cell hyperplasia and cilia loss is essential to understanding lung pathology. Significant insight has been gained regarding cytokine mediated mucous cell hyperplasia and increased mucus secretion with asthma, pulmonary infection, or lung injury (Elias et al., 1999; Kupperman et al., 2002; Renauld, 2001; Tekkanat et al., 2001; Zhu et al., 1999) . Although loss of cilia, in addition to mucous cell hyperplasia, has been described in asthma, respiratory infections and toxin exposure, little is known regarding the mechanisms of cilia loss or the repair mechanisms of the ciliated epithelium (Cokugras et al., 2001; Cutz et al., 1978; Konrodova et al., 1985; Look et al., 2001; Lundgren et al., 1988; Sisson et al., 1994; Tristam et al., 1998) . Cytokine regulation of gene expression is well established and provides a possible molecular mechanism for the loss of ciliated epithelial cells (Lee et al., 2001; Matsukura et al., 2001; Nguyen and Benveniste, 2000) . Considering its role in ciliogenesis, foxj1 provides a possible target gene for cytokine regulation in cilia loss (Brody et al., 2000; Chen et al., 1998) . We hypothesize that cytokine-mediated changes in the pulmonary epithelium include the loss of ciliated epithelial cells.
Furthermore, we propose that the loss of ciliated epithelial cells is mediated through cytokine inhibition of foxj1 expression. In this report, the cellular and molecular mechanisms of cilia loss in the airway epithelium in response to IL-13 are examined. Figures 1A, 2A , and 3B). To examine the effect of IL-13 on the differentiated phenotype, IL-13 at 50 or 100 ng/ml was added to the basal culture medium following culture of the tissue at air-liquid interface for 24 hours after arrival from Matek. The tissue was then cultured at 37 o C in 5.0% CO 2 for 3 to 8 days. The IL-13 concentrations and lengths of treatment were based on previous studies by other investigators demonstrating IL-13 mediated changes in the pulmonary epithelium with IL-13 concentrations and lengths of treatment in this same range (Laoukili et al., 2001; Lee et al., 2001; Tyner et al., 2006) .
Materials and Methods

Differentiated human airway epithelial tissue culture
Electron microscopy
For scanning electron microscopy, cultured human airway epithelial tissue was fixed in 2.5% (v/v) glutaraldehyde in 0.1 M sodium cacodylate and postfixed using the osmium-thiocarbohydrazideosmium (OTO) method (Kelly et al., 1973) . Samples were dehydrated in ascending concentrations For transmission electron microscopy, cultured human airway epithelial tissue was fixed with 2.5% (v/v) glutaraldehyde in 0.1M sodium cacodylate, postfixed in 1.0% (v/v) osmium tetraoxide and then stained with 1.0% (w/v) uranyl acetate. Tissue was dehydrated in ascending concentrations of ethanol prior to embedding in epoxy resin. Ultrathin sections were stained with uranyl acetate and lead citrate and then examined with an Hitachi H-600 transmission electron microscope.
Western blot analysis
Protein was isolated from cultured human airway epithelial tissue in the presence of protease inhibitors as described (Potter et al., 1998) . 10 mg of the cell extract were electrophoresed in 7.0%
(w/v) polyacrylamide-SDS and transferred to a PVDF membrane ( For immunofluorescence, a minimum of three independent sections from untreated or treated tissue was examined. Duplicate samples were included for each antibody and tissue as well as control samples with no primary antibody.
Transient transfection
2.2 kilobases of the mouse foxj1 promoter region were cloned into the pCAT3e reporter vector (Invitrogen). This region includes a consensus STAT binding element from -1260 to -1268 bp (Table 1) . Site-directed mutagenesis of the STAT-binding element was performed with the QuikChange II Site-Directed Mutagenesis Kit (Stratagene) according to the manufacturer's protocol.
DNA sequence analysis was performed to confirm the sequence of the mutated site (Table 1) in the absence or presence of 50 ng/ml of IL-13. After culture for 48 hours cells were lysed and the cell extract incubated with [ 14 C] chloramphenicol and n-butyrl CoA to assay for chloramphenicol acetlytransferase (CAT) activity. β-galactosidase activity was also assayed in aliquots of the cell lysate. The β-galactosidase activity was used to correct for transfection efficiency.
Statistical analysis
Experimental data were analyzed by one-way analysis of variance. Data are expressed as the mean ± standard error.
Results
IL-13 results in a loss of cilia from cultured differentiated airway epithelial tissue
To test if the cytokine IL-13 mediated the loss of ciliated epithelial cells from cultured, differentiated human airway epithelium, cells were treated with IL-13 at 50 ng/ml or 100 ng/ml (Figure 1 ). By scanning electron microscopy, 48 ± 7% (mean ± standard error) of untreated airway epithelial cells cultured for 3 days were ciliated ( Figure 1A ). In tissue treated with 50 ng/ml IL-13 for 3 days, the number of ciliated cells was reduced to 35 ± 9% ( Figure 1B ). When tissue was treated with 100 ng/ml IL-13 for 3 days, the number of ciliated cells was reduced to 10 ± 3% ( Figure 1C ). Treatment of differentiated airway epithelial cells with 100 ng/ml IL-13 for 8 days resulted in a complete loss of ciliated epithelial cells ( Figure 1D ). There is thus a dose-dependent decrease in ciliated cells in cultured airway epithelium in response to IL-13 ( Figure 1E ). This decrease was statistically significant by analysis of variance (p = 0.005).
In addition to the decrease in the number of ciliated epithelial cells following IL-13 treatment, there was also a decrease in the number of cilia per ciliated cell. Untreated, cultured ciliated cells had nearly 100% of the cell surface covered with cilia. This decreased to 78 ± 9% following treatment with 50 ng/ml of IL-13 for 3 days and decreased to 31 ± 8% following treatment with 100 ng/ml of IL-13 for 3 days. The decrease in the percentage of cell surface covered with cilia was statistically significant by analysis of variance (p < 0.001). Immunofluorescence with antibody to pericentrin of untreated airway epithelial tissue cultured for 3 days, reveals basal bodies in a linear arrangement at the apical surface of cells ( Figure   2A ). Staining of centrosomes can also be seen throughout the section. Following treatment of cultured airway epithelium with IL-13 at 50 ng/ml for 3 days or 100 ng/ml for 3 or 8 days, cells can be observed that have lost the apical localization of the pericentrin positive basal bodies (Figures 2B, C, and data not shown).
IL-
Transmission electron microscopy confirms the loss of apical basal body localization. In untreated airway epithelium cultured for 3 days, basal bodies were localized to the apical cell compartment where they anchor the axonemal structures ( Figure 2D ). Following treatment with IL-13 at 50 ng/ml for 3 days or 100 ng/ml for 3 or 8 days, basal bodies were distributed throughout the cytoplasm and not localized to the apical cell compartment ( Figure 2E , F, and data not shown). The number of basal bodies observed was markedly reduced in the tissue treated with 100 ng/ml of IL-13 for 8 days. This phenotype of axonemal loss and basal body mislocalization is similar to the respiratory epithelial phenotype of mice with a targeted mutation of the foxj1 gene (Brody et al., 2000; Gomperts et al., 2004) .
IL-13 decreases foxj1 expression by airway epithelial cells
Because of the similarity in phenotype between the IL-13 treated airway tissue and the airway of foxj1 -/-mice, we hypothesized that the loss of cilia in response to IL-13 was mediated through changes in foxj1 expression. Thus, expression of foxj1 in cultured human airway epithelial tissue treated with IL-13 was examined. By western blot analysis, there was a 50% decrease in the 65 kD foxj1 protein following treatment of airway epithelial tissue with 50 ng/ml of IL-13 for 3 days ( Figure 3A) . In order to determine if the decrease in foxj1 protein was the result of a decrease in foxj1 expressing cells, tissues were examined by immunofluorescence. In untreated airway epithelial tissue 39 ± 9% of the cells had nuclei positive for foxj1 ( Figure 3B ). Following treatment of the airway epithelial tissue for 3 days with 50 ng/ml IL-13, foxj1 localization remains nuclear but the percentage of foxj1 positive nuclei was decreased to 8 ± 5% of the cells (p = 0.01) ( Figure 3C , see also Figures 4B, 4C, and 6B). As has been previously reported, mucous cell hyperplasia was also noted following treatment of the airway epithelial cells with IL-13 (Kondo et al., 2002; Laoukili et al., 2001; Shim et al., 2001; Zhu et al., 1999) . In untreated airway epithelial tissue 11 ± 5% of the cells were positive for the mucous cell marker Muc-5AC ( Figure 3B ). The percentage of Muc-5AC positive cells increased to 28 ± 10% of cells following 3 days treatment with 50 ng/ml IL-13 (p = 0.04) ( Figure 3C ). A decrease in foxj1 positive nuclei and increase in Muc-5AC positive cells was also observed with 100 ng/ml IL-13 for 3 days (data not shown).
In addition to the decrease in foxj1 positive cells and mucous cell hyperplasia, cells with a mucociliary phenotype were observed following treatment with IL-13 (Figure 4) . In untreated airway epithelial tissues cultured for 3 days, no cells were observed that were positive for both foxj1
and Muc-5AC ( Figure 4A ). Following treatment with either 50 ng/ml or 100 ng/ml IL-13, cells were observed in the airway epithelium that were positive for both markers ( Figure 4B and C). Cells with a mucociliary phenotype have been previously reported following treatment with IL-13 (Tyner et al., 2006) .
To confirm the mucociliary phenotype, double immunofluorescence was performed with antibody to Muc-5AC and pericentrin ( Figure 5 ). In untreated airway epithelial cells cultured for 3 days, cells with apically localized pericentrin can be seen as separate from Muc-5AC positive cells ( Figure 5A ). Following treatment with either 50 ng/ml or 100 ng/ml IL-13 for 3 days, cells with a mucociliary phenotype are observed ( Figure 5B and data not shown). These cells contain both mislocalized basal bodies as indicated by the pericentrin staining, as well as being positive for the mucous cell marker Muc-5AC.
IL-13 decreases ezrin expression by airway epithelial cells
In foxj1 -/-mice, loss of axonemal structures and mislocalization of basal bodies from the apical cell compartment was associated with the loss of ezrin from the apical cell compartment (Gomperts et al., 2004; Huang et al., 2003) . We hypothesized that a similar mechanism might be involved in the IL-13 mediated loss of cilia. Treatment of cultured human airway epithelial tissue with IL-13 also resulted in a loss of ezrin from the apical cell compartment (Figure 6 ). By immunofluorescence of untreated tissue, ezrin is localized to the apical cell compartment of foxj1 positive cells ( Figure 6A ).
After treatment with IL-13 at 50 ng/ml or100 ng/ml, there is a loss of ezrin from the apical cell compartment in cultured human airway epithelial tissue ( Figure 6B and data not shown). This loss of apical ezrin coincides with the loss of foxj1 positive nuclei following IL-13 treatment.
IL-13 regulates expression of the foxj1 promoter
Because of the similarity in phenotype between IL-13 treated airway epithelial tissue and the airway epithelium of foxj1 -/-mice, as well as decreased foxj1 expression in response to IL-13, we hypothesized that IL-13 regulated foxj1 expression through binding of STAT protein to the foxj1
promoter. Sequence analysis of the mouse foxj1 promoter revealed a consensus STAT-binding element (SBE) at -1260 to -1268 bp (Table 1) . Examination of the sequence of the human FOXJ1
promoter revealed a conserved SBE at -1431 to -1439 bp (Table 1) . Co-transfection of BEAS 2B cells with a STAT-6 expression vector and CAT reporter plasmid with 2.2 kilobases of the mouse foxj1 promoter region resulted in a 50% decrease in CAT activity compared to the foxj1 promoterreporter plasmid alone ( Figure 7A ). Site-directed mutagenesis of the conserved SBE abrogated completely the STAT-6 inhibition of foxj1 promoter activity (Table 1 and Figure 7A ).
In order to analyze the effect of IL-13 on foxj1 promoter activity in BEAS 2B cells, it was first necessary to demonstrate that BEAS 2B cells could support the phosphorylation of STAT-6 in response to IL-13. To test for IL-13 induced phosphorylation of STAT-6 in BEAS 2B cells, western blot analysis of cell extract from IL-13 treated and untreated BEAS 2B cells was performed with antibody specific to phosphorylated STAT-6 ( Figure 7B ). In the untreated cells, no product was detected with primary antibody to phosphorylated STAT-6. In the treated cells, a 105 kD protein was detected with antibody to phosphorylated STAT-6 ( Figure 7B ). The control lane contains cell extract from interferon-γ treated Daudi cells. Transfection of BEAS 2B cells with a 2.2 kb foxj1
promoter-reporter plasmid in the presence of 50 ng/ml IL-13 resulted in a 50% decrease in promoter activity ( Figure 7C ).
Discussion
Changes in the pulmonary epithelial cell population are integral to the pathogenesis of a variety of pulmonary diseases including asthma and infection. Frequently, these changes include an increase in mucous cells and decrease in ciliated cells. The increased levels of airway cytokines, such as IL-13, associated with asthma and pulmonary infection suggest a role for these mediators in the changes observed in the airway epithelial phenotype (Barends et al., 2002; Mullings et al., 2001) . The central role played by IL-13 in mucous cell metaplasia and hyperplasia has been well described (Atherton et al., 2003; Kondo et al., 2002; Kupperman et al., 2002; Shim et al., 2001) . Polarization of epithelial cells into apical and basal compartments is essential for their normal function. Localization of proteins to the apical or basal compartment requires cellular mechanisms for segregating these proteins and then maintaining their appropriate localization (Wodarz, 2002) . Members of the ERM family of proteins, which includes ezrin, act to maintain anchoring of proteins to the apical cytoskeleton (Bretscher et al., 2002) . In the pulmonary epithelium, ezrin and the associated scaffold protein EBP-50 anchor basal bodies to the apical cytoskeleton (Gomperts et al., 2004; Huang et al., 2003) . In cultured human airway epithelium, the loss of cilia with IL-13 treatment was associated with a loss of apical ezrin. A similar observation was made following IL-13 treatment of differentiating nasal epithelial cultures (Laoukili et al., 2001 ). These observations are consistent with the loss of basal body anchoring to the apical cytoskeleton as the mechanism of cilia loss in response to IL-13. Changes in cytoskeletal proteins in response to IL-13 have also been observed during macrophage fusion (DeFife et al., 1999) . In addition to its role in basal body anchoring, ezrin acts to anchor a number of other airway epithelial proteins, such as the CFTR, to the apical cytoskeleton (Li et al., 2005) . The loss of apical ezrin in response to IL-13 may thus result in a more generalized airway epithelial dysfunction.
Targeted mutation of the mouse foxj1 gene resulted in a phenotype similar to that observed in airway epithelial cells in response to IL-13. Axonemal structures are absent with mislocalized basal bodies and loss of apical ezrin, as well as EBP-50 (Gomperts et al., 2004; Huang et al., 2003) . This similarity in phenotype led us to examine the possible regulation of foxj1 expression by IL-13.
Following IL-13 treatment of cultured airway epithelial cells, decreased foxj1 expression was detected. This appeared to be due primarily to a decrease in the number of foxj1 positive cells in the epithelium. Regulation of foxj1 expression by IL-13 is mediated by a conserved SBE located in the mouse and human foxj1 promoter. This suggests a molecular mechanism for cilia loss with decreased foxj1 expression resulting in a failure of basal body anchoring to the apical cytoskeleton and subsequent loss of axonemal structures. A similar decrease in foxj1 expression associated with loss of cilia was noted in mouse pulmonary epithelial cells during paramyxoviral infection (Look et al., 2001) . The decrease in foxj1 following paramyxoviral infection may be mediated by the increased airway levels of IL-13 observed following such infection (Barends et al., 2002; Johnson et al., 2003; Lukacs et al., 2001) . The proposed mechanisms for cilia loss in response to IL-13 are summarized in Figure 8 . 
